RU2012133274A - MEANS OF PEPTIDE STRUCTURE Possessing ANTI-INFLAMMATORY, ANTIBACTERIAL, WELL-HEALING, REGENERATIVE, ANALGETIC, ANTI-BURNING ACTION AND MEDICINAL FORMS ON ITS BASIS - Google Patents

MEANS OF PEPTIDE STRUCTURE Possessing ANTI-INFLAMMATORY, ANTIBACTERIAL, WELL-HEALING, REGENERATIVE, ANALGETIC, ANTI-BURNING ACTION AND MEDICINAL FORMS ON ITS BASIS Download PDF

Info

Publication number
RU2012133274A
RU2012133274A RU2012133274/15A RU2012133274A RU2012133274A RU 2012133274 A RU2012133274 A RU 2012133274A RU 2012133274/15 A RU2012133274/15 A RU 2012133274/15A RU 2012133274 A RU2012133274 A RU 2012133274A RU 2012133274 A RU2012133274 A RU 2012133274A
Authority
RU
Russia
Prior art keywords
regenerative
antibacterial
inflammatory
och
healing
Prior art date
Application number
RU2012133274/15A
Other languages
Russian (ru)
Other versions
RU2517213C2 (en
Inventor
Татьяна Георгиевна Емельянова
Людмила Сергеевна Гузеватых
Татьяна Александровна Воронина
Вадим Юрьевич Балабаньян
Андрей Михайлович Ульянов
Original Assignee
Татьяна Георгиевна Емельянова
Людмила Сергеевна Гузеватых
Татьяна Александровна Воронина
Вадим Юрьевич Балабаньян
Андрей Михайлович Ульянов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Татьяна Георгиевна Емельянова, Людмила Сергеевна Гузеватых, Татьяна Александровна Воронина, Вадим Юрьевич Балабаньян, Андрей Михайлович Ульянов filed Critical Татьяна Георгиевна Емельянова
Priority to RU2012133274/15A priority Critical patent/RU2517213C2/en
Priority to PCT/RU2013/000625 priority patent/WO2014021737A1/en
Publication of RU2012133274A publication Critical patent/RU2012133274A/en
Application granted granted Critical
Publication of RU2517213C2 publication Critical patent/RU2517213C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

1. Применение дипептида общей формулы Tyr-Pro-Х, где X - ОН, NH, ОСН, ОСНв качестве противовоспалительного, антибактериального, ранозаживляющего, регенеративного, анальгетического и противоожогового средства.2. Лекарственная форма, содержащая в качестве действующего вещества дипептид общей формулы Tyr-Pro-Х, где X - ОН, NH, ОСН, ОСН, применяемая в качестве противовоспалительного, антибактериального, ранозаживляющего, регенеративного, анальгетического и противоожогового средства.3. Форма по п.2, в виде одной из следующих лекарственных форм: мазь, гель, линимент, спрей, суппозитории, пластырь, орально-дезинтегрируемые таблетки, капли.1. The use of a dipeptide of the general formula Tyr-Pro-X, where X is OH, NH, OCH, OCH as an anti-inflammatory, antibacterial, wound healing, regenerative, analgesic and anti-burn agent. 2. A dosage form containing, as an active ingredient, a dipeptide of the general formula Tyr-Pro-X, where X is OH, NH, OCH, OCH, used as an anti-inflammatory, antibacterial, wound healing, regenerative, analgesic and anti-burn agent. 3. The form according to claim 2, in the form of one of the following dosage forms: ointment, gel, liniment, spray, suppositories, patch, oral disintegrating tablets, drops.

Claims (3)

1. Применение дипептида общей формулы Tyr-Pro-Х, где X - ОН, NH2, ОСН3, ОС2Н5 , в качестве противовоспалительного, антибактериального, ранозаживляющего, регенеративного, анальгетического и противоожогового средства.1. The use of a dipeptide of the general formula Tyr-Pro-X, where X is OH, NH 2 , OCH 3 , OS 2 H 5 , as an anti-inflammatory, antibacterial, wound healing, regenerative, analgesic and anti-burn agent. 2. Лекарственная форма, содержащая в качестве действующего вещества дипептид общей формулы Tyr-Pro-Х, где X - ОН, NH2, ОСН3, ОС2Н5, применяемая в качестве противовоспалительного, антибактериального, ранозаживляющего, регенеративного, анальгетического и противоожогового средства.2. A dosage form containing, as an active ingredient, a dipeptide of the general formula Tyr-Pro-X, where X is OH, NH 2 , OCH 3 , OS 2 H 5 , used as an anti-inflammatory, antibacterial, wound healing, regenerative, analgesic and anti-burn agent . 3. Форма по п.2, в виде одной из следующих лекарственных форм: мазь, гель, линимент, спрей, суппозитории, пластырь, орально-дезинтегрируемые таблетки, капли. 3. The form according to claim 2, in the form of one of the following dosage forms: ointment, gel, liniment, spray, suppositories, patch, oral disintegrating tablets, drops.
RU2012133274/15A 2012-08-03 2012-08-03 Agent of peptide structure possessing anti-inflammatory, antibacterial, wound-healing, regenerative, analgesic, burntreating action and based dosage forms RU2517213C2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
RU2012133274/15A RU2517213C2 (en) 2012-08-03 2012-08-03 Agent of peptide structure possessing anti-inflammatory, antibacterial, wound-healing, regenerative, analgesic, burntreating action and based dosage forms
PCT/RU2013/000625 WO2014021737A1 (en) 2012-08-03 2013-07-19 Pharmaceutical preparation of dipeptide tyr-pro with anti-inflammatory, antibacterial, wound-und burnhealing action

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2012133274/15A RU2517213C2 (en) 2012-08-03 2012-08-03 Agent of peptide structure possessing anti-inflammatory, antibacterial, wound-healing, regenerative, analgesic, burntreating action and based dosage forms

Publications (2)

Publication Number Publication Date
RU2012133274A true RU2012133274A (en) 2014-03-27
RU2517213C2 RU2517213C2 (en) 2014-05-27

Family

ID=49304294

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012133274/15A RU2517213C2 (en) 2012-08-03 2012-08-03 Agent of peptide structure possessing anti-inflammatory, antibacterial, wound-healing, regenerative, analgesic, burntreating action and based dosage forms

Country Status (2)

Country Link
RU (1) RU2517213C2 (en)
WO (1) WO2014021737A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3047596A1 (en) * 1980-12-17 1982-07-22 Victor Dipl.- Chem. 8000 München Brantl Neuroleptic tyrosyl-proline di:peptide derivs. - prepd. by conventional linking of the component aminoacid(s)
RU2007997C1 (en) 1992-07-08 1994-02-28 Леонидов Николай Борисович Methyluracil liniment
RU2139085C1 (en) * 1998-06-23 1999-10-10 Санкт-Петербургская общественная организация "Институт биорегуляции и геронтологии" Agent stimulating reparative processes and method of its use
WO2008020778A1 (en) * 2006-07-31 2008-02-21 Institut Molekulyarnoi Genetiki Rossiiskoi Akademii Nauk (Img Ran) Analgetically active peptide family
AU2011255258B2 (en) * 2010-05-21 2015-07-09 Cytogel Pharma, Llc Materials and methods for treatment of inflammation

Also Published As

Publication number Publication date
RU2517213C2 (en) 2014-05-27
WO2014021737A1 (en) 2014-02-06

Similar Documents

Publication Publication Date Title
AR124134A2 (en) TOPICAL USE FORMULATION FOR A JAK INHIBITOR
RS54438B1 (en) Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
EA201592250A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of diseases
EA201201680A1 (en) MORFOLINOPYRIMIDINES AND THEIR APPLICATION IN THERAPY
EA201591751A1 (en) TRIPEPTIDE EPOKEKETONE PROTEASE INHIBITORS
MD4736C1 (en) Polycyclic carbamoylpyridone compound and its pharmaceutical use
BR112015017997A8 (en) quinoline and quinoxaline amides as sodium channel modulators, pharmaceutical compositions comprising them and use
RU2016135431A (en) COMPOSITION FOR LOCAL TREATMENT OF THE RAS
EA201492290A1 (en) COMPOSITIONS AND METHODS FOR VAGINAL DELIVERY OF ANTIPROGHESTINES
EA201201050A1 (en) PYRAZOLES AS AN ANTAGONISTS CRTH2
BR112015030315A2 (en) 4-alkynylimidazole derivative and medicament comprising the same as active ingredient
RU2015102772A (en) Benzodiazelipas for small cell lung cancer
EA201891804A1 (en) TETRACYCLINE CONNECTIONS
CL2021003034A1 (en) Methods of treatment of sjögren's syndrome using a bruton's tyrosine kinase inhibitor
CO6592109A2 (en) New crystalline form of a cyclopropylbenzamide derivative
RU2014111070A (en) TREATMENT OF SYMPTOMS ASSOCIATED WITH GASTROParesis IN WOMEN
EA201490573A1 (en) CONTAINING BENZOTHIAZOLONE
UA113201C2 (en) FLUOROMATIC (3R, 4R, 5S) -5-GUANIDINO-4-FLORACYLAMIN-3- (PENTAN-3-ILOXY) CYCLOHEXEN-1-CARBOXYLIC ACIDS, THEIR ETHERS AND THE USE
HRP20171299T1 (en) Combinations with a backbone-cyclized peptide
RU2012133274A (en) MEANS OF PEPTIDE STRUCTURE Possessing ANTI-INFLAMMATORY, ANTIBACTERIAL, WELL-HEALING, REGENERATIVE, ANALGETIC, ANTI-BURNING ACTION AND MEDICINAL FORMS ON ITS BASIS
RU2012135798A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SKIN ITCH
EA201400365A1 (en) NEW THYRODUCT LACTS AS HIGHLY ACTIVE HDAC INHIBITORS AND THEIR APPLICATION AS MEDICINES
AR054361A1 (en) USE OF PROPENOUS METOXIDIFENIL ADAMANTIL ACID FOR THE TREATMENT OF DERMATOLOGICAL DISEASES
RU2008115908A (en) PHARMACEUTICAL COMPOSITION CONTAINING HYALURONIDASE AND LIPOSOMES FOR EXTERNAL USE
RU2012133272A (en) AN ANALGETIC, ANTI-INFLAMMATORY ACTION PEPTIDE STRUCTURE AND MEDICINAL FORM ON ITS BASIS

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20190804